The involvement of IL-1 in RA has previously been shown by clinical improvement in patients on IL-1 receptor antagonist (IL-1Ra) therapy, reducing both clinical signs of inflammation and joint erosion 27. Here, IL1A is linked to rheumatoid arthritis.